Grievance regarding the DAL-DO Incentive Awards Program

NTEU Chapter 254 has filed a grievance in representation of bargaining unit employees (BUE) in FDA’s Dallas District Office (DAL-DO) against DAL-DO management after it failed to comply with Article 27 of the 2014 HHS-NTEU Consolidated Collective Bargaining Agreement (CBA) as it relates to the DAL-DO Incentive Awards Program.

During this Fiscal Year 2016 so far, the DAL-DO incentive awards committee has not met to develop guidelines or criteria for recommending which nominees receive awards or a nomination form that complies with Article 27 of the CBA.

Additionally, the committee has failed to meet quarterly to make recommendations; therefore, awards have not been given as close in time as possible to the achievement being recognized.

Overbearing boss, "You don't need NTEU. I will take care of you."Upon investigation, NTEU Chapter 254 found that a management official not appointed to the committee has been performing some of the functions of the committee and siding with the non-BUE committee member against the BUE committee member when trying to bring the committee into compliance with Article 27.

Furthermore, DAL-DO management has unilaterally decided not to grant any incentive cash awards, thus limiting incentive awards to time off only.

We encourage you to provide information relevant to this case so we can best protect your rights, and we also welcome your questions and comments.

Author: chapterpresident

I have worked in the FDA since 1990 in a variety of positions. I currently serve as chapter president of NTEU Chapter 254, representing FDA employees in Arkansas, Colorado, Iowa, Kansas, Missouri, Nebraska, New Mexico, Oklahoma, Texas, and Utah.